Earlier last month, Sirius XM Holdings Inc’ majority owner Liberty Media Corp. (LMCA), which is controlled by media mogul John Malone, offered to buy around 48% of Sirius XM Holdings Inc. (SIRI) it does not already own in a deal that could be worth more than $10 billion. Sirius XM Holdings Inc. (NASDAQ:SIRI) stock performance…
The Rosen Law Firm, P.A. reminds purchasers of Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) between March 15, 2012 and January 9, 2014, inclusive (the “Class Period”) of the important Mach 17, 2014 lead plaintiff deadline in the class action seeking remedies under the federal securities laws. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) stock performance was -5.40% in last session…
The online flash-sale retailer Zulily Inc (NASDAQ:ZU) blew through Wall Street’s expectations when it announced fourth-quarter results that showed, among other highlights, a doubling in revenues year-on-year. Zulily Inc (NASDAQ:ZU) stock performance was -7.34% in last session and finished the day at $61.72. Traded volume was 2.54million shares in the last session and the average volume…
Equities research analysts at Deutsche Bank assumed coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a research note issued to investors on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $45.00 price target on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock performance was 24.46% in last session and finished the day…
Renren Inc (NYSE:RENN) options set a new 90-day record for the number of contracts that exchanged hands between the buyers and the sellers on both the call and put side. Renren Inc (NYSE:RENN) stock performance was 22.56% in last session and finished the day at $4.78. Traded volume was 16.87million shares in the last session…
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) has been trading with ups and downs since the past few days, after the company announced better-than-expected results and its plans to partner for its flagship drug Iclusig. One of the major takeaway during the earnings call is Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)’s CEO Harvey Berger’s indication for potential partnership in Japan…
Tech Analysis & Market News